UNCY compared with TLPH: revenue, margins and what each company keeps, and the suppliers and customers both name

UNCYUnicycive Therapeutics, Inc.

Mkt capRevenueRevenue

TLPHTalphera, Inc.

Mkt capRevenueRevenue

Compare

UNCYUnicycive Therapeutics, Inc.

TLPHTalphera, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

UNCY, solidTLPH, dashed

Supply-chain overlap

Revenue flow

UNCY: latest quarter not drawable. TLPH: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only UNCY 1

—Shilpa Medicareunlistedsupplier

Shared 0

No shared counterparties.

Only TLPH 1

—Laboratoire Aguettantunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

UNCYUnicycive Therapeutics, Inc.

3.75▼−1.56%· post 3.15

Mkt cap$100.7MRevenue—

TLPHTalphera, Inc.

1.05▼−1.87%· post 1.04

ClosedOct 30 '26

Mkt cap$53.5MRevenue$1,000Q3 FY25

Compare

ClosedOct 30 '26

UNCYUnicycive Therapeutics, Inc.

TLPHTalphera, Inc.

3.75▼−1.56%post 3.15

Price

1.05▼−1.87%post 1.04

$100.7M

Mkt cap

$53.5M

—

Revenue

$1,000Q3 FY25

UNCY3.75▼−1.56%vsTLPH1.05▼−1.87%ClosedOct 30 '26